Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene
- 1 September 1995
- journal article
- Published by Elsevier BV in Cell
- Vol. 82 (6), 981-988
- https://doi.org/10.1016/0092-8674(95)90277-5
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Signaling by ABL oncogenes through cyclin D1.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 geneNature, 1994
- Differential Complementation of Bcr-Abl Point Mutants with c-MycScience, 1994
- Human Sos1: a Guanine Nucleotide Exchange Factor for Ras that Binds to GRB2Science, 1993
- Transplantation of Normal and Leukemic Human Bone Marrow into Immune‐Deficient Mice: Development of Animal Models for Human HematopoiesisImmunological Reviews, 1991
- Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene.Molecular and Cellular Biology, 1991
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990
- Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinasesNature, 1990
- The Molecular Genetics of Philadelphia Chromosome–Positive LeukemiasNew England Journal of Medicine, 1988
- An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activityCell, 1984